Pyxis Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.6%.

Top 25 shareholders own 79.05% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.8%	Pfizer Inc.	7,032,770	US$25.5m	18.2%	no data
10%	Ridgeback Capital Management LLC	5,956,443	US$21.6m	37.1%	33.78%
7.04%	Deep Track Capital, LP	4,184,100	US$15.1m	0%	0.42%
6.5%	Laurion Capital Management LP	3,861,179	US$14.0m	0%	0.47%
5.72%	Lara Sullivan	3,399,173	US$12.3m	82.1%	no data
4.69%	BlackRock, Inc.	2,785,895	US$10.1m	766%	no data
4.61%	Bayer Aktiengesellschaft	2,742,338	US$9.9m	0%	no data
4.31%	Balyasny Asset Management L.P.	2,562,942	US$9.3m	-1.21%	0.02%
3.47%	The Vanguard Group, Inc.	2,060,444	US$7.5m	47%	no data
2.8%	Ikarian Capital, LLC	1,662,408	US$6.0m	0%	1.82%
2.25%	Millennium Management LLC	1,336,908	US$4.8m	129%	no data
2.02%	StemPoint Capital LP	1,202,675	US$4.4m	-33%	1.26%
1.82%	Pfizer Venture Investments LLC	1,080,507	US$3.9m	0%	99.99%
1.76%	CHI Advisors LLC	1,046,025	US$3.8m	0%	1.41%
1.73%	Geode Capital Management, LLC	1,027,711	US$3.7m	202%	no data
1.46%	Pamela Connealy	866,061	US$3.1m	63.7%	no data
1.25%	State Street Global Advisors, Inc.	742,907	US$2.7m	579%	no data
1.19%	abrdn plc	708,303	US$2.6m	0%	no data
0.83%	Boothbay Fund Management, LLC	492,462	US$1.8m	0%	0.06%
0.82%	Superstring Capital Management LP	484,443	US$1.8m	-1.89%	2.14%
0.73%	John Flavin	435,712	US$1.6m	15.3%	no data
0.64%	Hillhouse Investment Management, Ltd.	382,606	US$1.4m	0%	0.01%
0.55%	Decheng Capital LLC	326,810	US$1.2m	0%	0.34%
0.52%	BNY Asset Management	311,630	US$1.1m	92.2%	no data
0.47%	Thomas Civik	279,802	US$1.0m	26.1%	no data